Therapeutic Genome Editing With CRISPR/Cas9 in a Humanized Mouse Model Ameliorates α1-antitrypsin Deficiency Phenotype
α1-antitrypsin (AAT) is a circulating serine protease inhibitor secreted from the liver and important in preventing proteolytic neutrophil elastase associated tissue damage, primarily in lungs. In humans, AAT is encoded by the SERPINA1 (hSERPINA1) gene in which a point mutation (commonly referred to...
Main Authors: | Mikael Bjursell, Michelle J. Porritt, Elke Ericson, Amir Taheri-Ghahfarokhi, Maryam Clausen, Lisa Magnusson, Therese Admyre, Roberto Nitsch, Lorenz Mayr, Leif Aasehaug, Frank Seeliger, Marcello Maresca, Mohammad Bohlooly-Y, John Wiseman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-03-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396418300690 |
Similar Items
-
In vivo genome and base editing of a human PCSK9 knock-in hypercholesterolemic mouse model
by: Alba Carreras, et al.
Published: (2019-01-01) -
Development of an ObLiGaRe Doxycycline Inducible Cas9 system for pre-clinical cancer drug discovery
by: Anders Lundin, et al.
Published: (2020-09-01) -
Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH.
by: Mikael Bjursell, et al.
Published: (2013-01-01) -
Improving Precise CRISPR Genome Editing by Small Molecules: Is there a Magic Potion?
by: Nadja Bischoff, et al.
Published: (2020-05-01) -
Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
by: Francesco Callea, et al.
Published: (2018-05-01)